Dumitru Mişcalencu, Lăcrămioara Ivanciu, Florica Mailat, Cristina Bordea, Oncogene virale

 

1. Souyri M., Vigon I., Charon M., Tambourin P., Oncogenicity of human N-ras oncogene and proto-oncogene introduced into retroviral vectors.   J. Virol., 1989, 63, 9, 3944-3953.

2. Kinsella A. R., Fiszer-Maliszewska L., Mitchel E., Guo Y. P., Fox M., Scott O., Introduction of the activated N-ras oncogene into human fibroblasts by retroviral vector induces morphological transformation and tumorogenity.   Carcinogenesis, 1990, 10, 1803–1809.

3. Hamburger V., Logsiffoul A., Bockaert J., Grandes et petites proteins G dans trafic vesiculaire. Annales d’Endocrinologie (Paris), 1996, 57, 83-90.

4. Shields J. M., Rogers-Graham K., Der C. J., Loss of transgelin in breast and colon tumors and in RIE-1 cells by Ras deregulation of gene expression through Raf-1 independent pathways. J. Biol. Chem. 2001 Dec.28.

5. Stacey D., Kazlauskas A., Regulation of Ras signaling by the cell cycle. Curr. Opin. Genet. Dev. 2002, 12(1), 44–6.

6. Park T. J., Han S.U., Cho Y. K., Paik W. K., Kim Y. B., Lim I. K., Methylation of O(6)-methylguanine-DNA methyltransferase gene is associated significantly with K-ras mutation, lymph node invasion, tumor staging, and disease free survival in patients with gastric carcinoma.Cancer, 2001, 92(11), 2760-8.

7. Alguacil J., Porta M., Malats N., Kauppinen T., Kogevinas M., Benavides F. G., Partanen T., Carrato A.,    Occupational exposure to organic solvents and K-ras mutations in exocrine pancreatic cancer.    Carcinogenesis, 2002, 23(1), 101-106.

8. Lu X., Xu T., Qian J., An application value of detecting K-ras and p53 gene mutation in the stool and pure pancreatic juice for diagnosis of early pancreatic cancer. Zhonghua Yi Xue Za Zhi, 2001, 81(17), 1050-3.

9. Hiyama T., Haruma K., Kitadai Y., Masuda H., Miyamoto M., Tanaka S., Yoshihara M., Shimamoto F., Chayama K., K-ras mutation in helicobacter pylori-associated chronic gastritis in patients with and without gastric cancer.   Int. J. Cancer, 2002, 97(5), 562-6.

10. Fisher G. H., Wellen S. L., Klimstra D., Lenczowski J. M., Tichelaar J. W., Lizak M. J., Whitsett J. A., Koretsky A, Varmus HE.   Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes Dev., 2001, 15(24), 3249-62.

11. Jackson E. L., Willis N., Mercer K., Bronson R. T., Crowley D., Montoya R., Jacks T., Tuveson D. A.,    Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.   Genes Dev., 2001, 15(24), 3243-8.

12. Kato K., Horiuchi S., Takahashi A., Ueoka Y., Arima T., Matsuda T., Kato H., Nishida J. J., Nakabeppu Y., Wake N., Contribution of estrogen receptora (Era) to oncogenic K-Ras-mediated NIH3T3 cell transformation and its implication for escape from senescence by modulating the p53 pathway. J. Biol. Chem., 2002 Jan 7.

13. Zhu S., Yoon K., Sterneck E., JohnsonP. F., Smart R.C., CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling. Proc. Natl. Acad. Sci. USA, 2002, 99(1), 207-212.

14. Zacharatos P., Kotsinas A., Tsantoulis P., Evangelou K., Kletsas D., Asimacopoulos P. J., Doussis-Anagnostopoulou I., Pezzella F., Gatter K., Papavassiliou A. G., Kittas C., Gorgoulis V. G.,   Relationship of the K-ras/c-mos expression patterns with angiogenesis in non-small cell lung carcinomas.Mol. Med., 2001, 7(9), 590-7.

15. Breier G., Blum S., Peli J., Groot M., Wild C., Risau W., Reichmann E., Transforming growth factor- beta and Ras regulate the VEGF/VEGF-receptor system during tumor angiogenesis. Int. J. Canecer, 2002, 97(2), 142-8.

16. Janda E., Lehmann K., Killisch I., Jechlinger M., Herzig M., Downward J., Beug H., Grunert S., Ras and TGF(beta) cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J. Cell. Biol. 2002, 156(2), 299-314.

17. Zhou M., Horita D. A., Waugh D. S., Byrd R. A., Marrison D. K., Solution Structure and Functional Analysis of the Cysteine-rich C1 Domain of Kinase Suppressor of Ras (KSR). J. Mol. Biol. 2002, 315(3), 435-46.

18. Wang Y., Waldron R. T., Dhaka A., Patel A., Riley M. M., Rozengurt E., Colicelli J., The RAS effector RINI directly competes with RAF and is regulated by 14-3-3 proteins.   Mol. Cell. Biol. 2002, 22(3), 916-26.

19. Wessler S., Rapp U. R., Wiedenmann B., Meyer T. F., Schoneberg T., Hocker M., Naumann M., B-Raf/Rap1 signaling, but not c-Raf-1/Ras, induces the histidine decarboxylase promoter in Helicobacter pylori infection. FASEB J. 2002 Jan. 14.

20. Colombo L. L., Lopez M. C., Chen G., Watson R. R., In vitro response of v-Ha-ras transgenic mouse lymphocytes after in vivo treatment with cocaine. Immunopharmacol. Immunotoxicol. 2001, 23(4), 607-16.

21. Colombo L. L., Lopez M. C., Chen G., Watson R. R., In vitro response of v-Ha-ras transgenic mouse lympho-cytes after in vivo treatment with alcohol.Immunopharmacol. Immunotoxicol. 2001, 23(4), 597-606.

22. Chakravarti D., Mailander P. C., Li K. M., Higginbotham S., Zhang H. L., Gross M. L., Meza J. L., Cavalieri EL, Rogan EG. Evidence that a burst of DNA depurination in SENCAR mouse skin induces error - prone repair and forms mutations in the H-ras gene. Oncogene, 2001, 20(55), 7945-53.

23. Yan Z., Kim G. Y., Deng X., Friedman E., TGF(beta)1 induces proliferation in colon carcinom cells by Ras-dependent, Smad-independent downregulationof p21cip1. J. Biol. Chem. 2002 Jan 9.

24. Sheta E. A., Trout H., Gildea J. J., Harding M. A., Theodorescu D., Cell density mediated pericellular hypoxia leads to induction of HIF-1alpha via nitric oxide and Ras/MAP kinase mediated signaling pathways. Oncogene, 2001, 20(52), 7624-34.

 

Cuprins

© University of Bucharest 2002. All rights reserved.

No part of this text may be reproduced in any form without written permission of the University of Bucharest, except for short quotations with the indication of the website address and the web page.

Comments to: Dumitru Mişcalencu, Lăcrămioara Ivanciu, Florica Mailat, Cristina Bordea
Last update: September 2002
Text editor: Monica CIUCIU